Chemoinformaics analysis of 4,21-Dehydrogeissoschizine
| Molecular Weight | 351.426 | nRot | 2 |
| Heavy Atom Molecular Weight | 328.242 | nRig | 12 |
| Exact Molecular Weight | 351.17 | nRing | 4 |
| Solubility: LogS | -0.492 | nHRing | 3 |
| Solubility: LogP | 0.239 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 49 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 26 | No. of Aromatic Carbocycles | 1 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 23 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 21 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 2 | No. of Arom Atom | 9 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 10 |
| nHA | 3 | APOL | 55.0122 |
| nHD | 2 | BPOL | 27.9578 |
| QED | 0.745 |
| Synth | 3.881 |
| Natural Product Likeliness | 0.926 |
| NR-PPAR-gamma | 0.01 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.101 |
| Pgp-sub | 0.157 |
| HIA | 0.399 |
| CACO-2 | -4.931 |
| MDCK | 0.00000527 |
| BBB | 0.572 |
| PPB | 0.264437 |
| VDSS | 1.308 |
| FU | 0.827703 |
| CYP1A2-inh | 0.004 |
| CYP1A2-sub | 0.075 |
| CYP2c19-inh | 0.014 |
| CYP2c19-sub | 0.962 |
| CYP2c9-inh | 0 |
| CYP2c9-sub | 0.054 |
| CYP2d6-inh | 0.543 |
| CYP2d6-sub | 0.905 |
| CYP3a4-inh | 0.001 |
| CYP3a4-sub | 0.736 |
| CL | 11.613 |
| T12 | 0.734 |
| hERG | 0.096 |
| Ames | 0.119 |
| ROA | 0.05 |
| SkinSen | 0.732 |
| Carcinogencity | 0.473 |
| EI | 0.019 |
| Respiratory | 0.948 |
| NR-Aromatase | 0.001 |
| Antiviral | Yes |
| Prediction | 0.66832 |